Legal status · Australia
Is Supaglutide legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Supaglutide is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Supaglutide in Australia at a glance
| Classification | Not approved |
|---|---|
| Note | Not registered with the TGA. |
| TGA approval status | Not approved by TGA |
| Human studies cited | 3 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Supaglutide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing Supaglutide is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What Supaglutide is
Approved in China in January 2025 for type 2 diabetes, on the back of two adaptive phase 2b/3 trials in more than 700 adults. Nearly everything indexed under the name supaglutide is monkey and mouse work, because the clinical programme is indexed under efsubaglutide alfa.
This compound is the clearest example on this site of a drug being invisible for reasons that have nothing to do with its evidence. Search PubMed for supaglutide and you get six records: insulin secretion in mouse and human islets, glucose control in diabetic mice, weight and brown fat markers in high fat diet mice, pharmacokinetics in rats and monkeys, glucose homeostasis in diabetic rhesus monkeys, and liver fat in monkeys with spontaneous steatohepatitis.
Mechanism: A recombinant fusion protein in which human GLP-1 is linked to the Fc fragment of human immunoglobulin G2. The Fc domain confers a long circulating half-life through neonatal Fc receptor recycling, the same mechanism dulaglutide uses, rather than through albumin binding by a fatty acid side chain.
Regulatory history: Not approved in the United States. Approved by China's National Medical Products Administration in January 2025 for glycaemic control in adults with type 2 diabetes, under the name efsubaglutide alfa, and included in China's national reimbursement drug list. Not approved for weight management anywhere.
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Supaglutide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Supaglutide in other countries
Frequently asked questions
Is Supaglutide legal in Australia?
No. Supaglutide is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile. Note: Not registered with the TGA.
Can I buy Supaglutide in Australia?
No approved product exists to buy. In Australia Supaglutide is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Not registered with the TGA.
Is Supaglutide TGA approved?
No. In Australia Supaglutide is classified as "Not approved", which is not a TGA marketing approval. For comparison, the US FDA status is: Not approved in the United States. Approved by China's National Medical Products Administration in January 2025 for glycaemic control in adults with type 2 diabetes, under the name efsubaglutide alfa, and included in China's national reimbursement drug list. Not approved for weight management anywhere.. On the evidence, 3 human studies are cited on its profile.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Supaglutide live on its compound profile.
Supaglutide profileThis page is general information about the regulatory status of Supaglutide in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.